TriangleFOR PATIENTS · SOURCE READING
Targeted therapy
Source: Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: March 6, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells.
Source links and citations
Tyrosine kinase inhibitor (TKI) therapy: TKI therapy blocks signals that tumors need to grow. TKIs block the enzyme tyrosine kinase that causes stem cells to become more blood cells (blasts) than the body needs. Imatinib mesylate (Gleevec) is used to treat myelodysplastic/myeloproliferative neoplasm, unclassifiable.
Source links and citations
For more information, see Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice